Current evidence and future directions for research with omega-3 fatty acids and attention deficit hyperactivity disorder

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 2, 2015, Pages 133-138

  Gow, Rachel V ^a   Hibbeln, Joseph R ^a   Parletta, Natalie ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Attention deficit hyperactivity disorder; Docosahexaenoic acid; Eicosapentaenoic acid; Highly unsaturated fatty acids; Omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; METHYLPHENIDATE; OMEGA 3 FATTY ACID; CENTRAL STIMULANT AGENT;

ADJUVANT THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG EFFICACY; EVIDENCE BASED PRACTICE; FUTUROLOGY; HUMAN; INTERVENTION STUDY; MENTAL PATIENT; META ANALYSIS (TOPIC); MONOTHERAPY; NUTRITIONAL DEFICIENCY; NUTRITIONAL INTOLERANCE; PSYCHOPHARMACOTHERAPY; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD; CHILD; CHILD NUTRITION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; FATTY ACIDS, OMEGA-3; HUMANS; METHYLPHENIDATE;

EID: 84922677004     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000140     Document Type: Article

References (28)

1. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011; 50:991-1000.
2. Strickland AD. Prevention of cerebral palsy, autism spectrum disorder, and attention deficit-hyperactivity disorder. Med Hypotheses 2014; 82:522-528.
3. Gow RV, Hibbeln JR. Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors. Child Adolesc Psychiatr Clin N Am 2014; 23:555-590.
4. Sinn M, Milte CM, Howe PR. Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients 2010; 2:128-170.
5. MilteCM, Parletta N, Buckley JD, et al. Increased erythrocyte eicosapentaenoic acid and docosahexaenoic acid are associated with improved attention and behaviour in children with ADHD in a 12-month randomised controlled threeway crossover trial. J Attent Disord 2013; doi: 10.1177/1087054713510562. [Epub ahead of print]
6. Milte CM, Parletta N, Buckley JD, et al. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial. Nutrition 2012; 28:670-677.
7. Viding E. Annotation: understanding the development of psychopathy. J Child Psychol Psychiatry 2004; 45:1329-1337.
8. Viding E, Jones AP, Frick PJ, et al. Heritability of antisocial behaviour at 9: do callous-unemotional traits matter? Dev Sci 2008; 11:17-22.
9. Gow RV, Vallee-Tourangeau F, Crawford MA, et al. Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2013; 88:411-418.
10. Frick PJ, Stickle TR, Dandreaux DM, et al. Callous-unemotional traits in predicting the severity and stability of conduct problems and delinquency. J Abnormal Child Psychol 2005; 33:471-487.
11. Frick PJ, White SF. Research review: the importance of callous-unemotional traits for developmental models of aggressive and antisocial behavior. J Child Psychol Psychiatry 2008; 49:359-375.
12. Raine A, Portnoy J, Liu J, et al. Reduction in behavior problems with omega-3 supplementation in children aged 8-16 years: a randomized, double-blind, placebo-controlled, stratified, parallel-group trial. J Child Psychol Psychiatry 2014; doi: 10.1111/jcpp.12314. [Epub ahead of print]
13. Widenhorn-Müller K, Schwanda S, Scholz E, et al. Effect of supplementation with long-chain v-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids 2014; 91:49-60.
14. Barragan E, Breuer D, Dopfner M. Efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD. J Attent Disord 2014; doi: 10.1177/1087054713518239. [Epub ahead of print]
15. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on ADHD-related problems with attention and behaviour. J Dev Behav Pediatr 2007; 28:82-91.
16. Behdani F, Hebrani P, Naseraee A, et al. Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients? J Res Med Sci 2013; 18:653-658.
17. Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev 2014; 34:496-505.
18. Puri BK, Martins JG. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2014; 90:179-189.
19. Sonuga-Barke EJS, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments. Am J Psychiatry 2013; 170:275-289.
20. Heilskov Rytter MJ, Andersen LB, Houmann T, et al. Diet in the treatment of ADHD in children: a systematic review of the literature. Nordic J Psychiatry 2014; doi: 10.3109/08039488.2014.921933. [Epub ahead of print]
21. Sinn N. Nutritional and dietary influences on attention deficit hyperactivity disorder. Nutr Rev 2008; 66:558-568.
22. Raz R, Carasso RL, Yehuda S. The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind place-bo- controlled study. J Child Adolesc Psychopharmacol 2009; 19:167-177.
23. Voigt RG, Llorente AM, Jensen CL. A randomized, double-blind, placebocontrolled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 2001; 139:189-196.
24. McCann D, Barrett A, Cooper A, et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 2007; 370:1560-1567.
25. Richardson AJ, Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatr 2005; 115:1360-1366.
26. Richardson AJ, Burton JR, Sewell RP, et al. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (The DOLAB Study). PloS One 2012; 7:e43909.
27. Johnson M, Ostlund S, Fransson G, et al. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder. J Atten Disord 2008; 12:394-401.
28. Milte CM, Sinn N, Buckley JD, et al. Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. J Child Healthcare 2011; 15:299-311.